Establishment Labs, a NYC-based global medical device company, secured up to $15m in debt funding.
Backers included Perceptive Advisors, JW Asset Management LLC and Relativity Healthcare Fund.
The company intends to use the funds to strengthen its financial position, to continue to expand its Motiva Implants® in the international market, finalize ita new manufacturing facility and start United States Food and Drug Administration trials.
Led by Juan José Chacón Quirós, CEO, Establishment Labs is a breast implant and medical technology company that designs, develops, manufactures and markets an product portfolio consisting of advanced silicone-filled breast and body shaping implants. The CE-marked Motiva Implants® line is manufactured in full compliance with ISO and EU requirements, and certified under the Medical Device Directive 93/42/EEC.